Drugscreens.com Adds SAFElife CLIA-Waived Urine Cups, Dip Cards and Saliva Kits for B2B Buyers
Boerne, United States – May 3, 2026 / DrugScreens.com /
DrugScreens.com expanded its B2B product catalog in October with the addition of the SAFElife drug test lineup, giving staffing firms, safety-sensitive employers, and clinical programs direct access to a broad range of workplace screening supplies. The move adds three distinct product lines to the platform, each designed to meet specific testing requirements without requiring buyers to work through multiple vendors.
What the SAFElife Lineup Covers
The addition centers on three product categories, each serving a different testing scenario. The first is a series of CLIA-waived and Forensic Use Only urine cups that detect both fentanyl and EtG alongside standard drug panels. Fentanyl detection has become a priority for many employers and clinical programs as the substance has appeared more frequently in workplace drug screens. EtG detection addresses alcohol use, making these cups useful for programs that monitor both substance categories.
The second product line consists of CLIA-waived dip cards, which offer a flexible format for organizations that prefer card-based testing over integrated cup systems. Like the urine cups, these carry CLIA-waived status, which is relevant for clinical settings where regulatory compliance is a factor in product selection.
The third line includes saliva drug test kits available in two classifications – Forensic and E&I. The saliva drug test kits do not include fentanyl detection, which is consistent with current oral fluid testing technology limitations, and are suited for employers who require non-invasive collection methods or who operate in environments where urine collection is not practical.
Who the Products Are Built For
Drugscreens.com positions these products specifically for B2B buyers operating within the continental United States. The platform does not perform testing services. It supplies the physical products to organizations that conduct their own screening programs – primarily human resources departments, safety officers, procurement teams, and program administrators at staffing agencies and healthcare-adjacent facilities.
The SAFElife drug test products carry tamper-resistant features and are designed for fast result turnaround, which matters for organizations running high-volume screening programs. Staffing firms in particular often require quick screening cycles to meet client onboarding timelines. Safety-sensitive employers in transportation, construction, and manufacturing face their own compliance pressures, and the CLIA-waived urine cups address both the regulatory and detection requirements those buyers face.
Context for the October Expansion
The SAFElife line has been part of the drugscreens.com catalog since October, giving the platform several months of practical experience with the products across its buyer base. That track record includes use by staffing firms, safety-sensitive employers, and clinical programs – three segments with distinct but overlapping needs around panel coverage, compliance status, and collection format.
Ordering and Availability
All three SAFElife product lines ship to buyers throughout the continental US. Orders are fulfilled on a B2B basis, with no retail or direct-to-consumer sales. Procurement teams can access the full SAFElife catalog, including the urine cups, dip cards, and saliva drug test kits, directly through drugscreens.com. Panel configurations, classifications, lot documentation, and volume pricing details are available through the platform for qualified business buyers.
About drugscreens.com
Drugscreens.com is a B2B supplier of workplace and clinical drug testing products serving buyers throughout the continental United States. The platform carries a range of screening supplies including urine cups, dip cards, and oral fluid collection kits from multiple product lines. It does not provide testing services and sells exclusively to business customers including staffing agencies, employers, and clinical program administrators.
Learn more at DrugScreens.com
Contact Information:
DrugScreens.com
1415 E. Blanco Rd, Suite 10-110
Boerne, TX 78006
United States
Ryan J. McClure
+1 800-652-3502
https://drugscreens.com